Literature DB >> 26580156

Perspective: The risks of overdiagnosis.

Alexandra Barratt1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26580156     DOI： 10.1038/527S104a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

2.  Quantifying the benefits and harms of screening mammography.

Authors:  H Gilbert Welch; Honor J Passow
Journal:  JAMA Intern Med       Date:  2014-03       Impact factor: 21.873

3.  Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.

Authors:  Jolyn Hersch; Alexandra Barratt; Jesse Jansen; Les Irwig; Kevin McGeechan; Gemma Jacklyn; Hazel Thornton; Haryana Dhillon; Nehmat Houssami; Kirsten McCaffery
Journal:  Lancet       Date:  2015-02-18       Impact factor: 79.321

4.  Rethinking screening for breast cancer and prostate cancer.

Authors:  Laura Esserman; Yiwey Shieh; Ian Thompson
Journal:  JAMA       Date:  2009-10-21       Impact factor: 56.272

Review 5.  Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.

Authors:  Jamie L Carter; Russell J Coletti; Russell P Harris
Journal:  BMJ       Date:  2015-01-07

Review 6.  The benefits and harms of breast cancer screening: an independent review.

Authors: 
Journal:  Lancet       Date:  2012-10-30       Impact factor: 79.321

Review 7.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04
  7 in total
  2 in total

1.  Tumor biology, clinicopathological characteristics and prognosis of screen detected T1 invasive non-palpable breast cancer in asymptomatic Chinese women (2001-2014).

Authors:  Bo Pan; Ru Yao; Yi-Dong Zhou; Qing-Li Zhu; Jie Shi; Qian-Qian Xu; Chang-Jun Wang; Shan-Shan You; Feng Mao; Yan Lin; Song-Jie Shen; Zhi-Yong Liang; Yu-Xin Jiang; Qiang Sun
Journal:  Oncotarget       Date:  2017-04-18

2.  Why precision medicine is not the best route to a healthier world.

Authors:  Juan Pablo Rey-López; Thiago Herick de Sá; Leandro Fórnias Machado de Rezende
Journal:  Rev Saude Publica       Date:  2018-02-05       Impact factor: 2.106
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.